Jerry R. Youkey
Corporate Officer/Principal at University of South Carolina
Profile
Jerry R.
Youkey is currently an Associate Dean at the Medical University of South Carolina and a Professor & Associate Dean at the University of South Carolina.
He was formerly the Chairman of Oncolix, Inc. and the Chief Academic Officer & Executive Vice President of Greenville Hospital System (South Carolina).
He also served as the Chief-Surgery Department at Geisinger Medical Center.
Dr. Youkey received his undergraduate degree from Stanford University and his doctorate from The Medical College of Wisconsin, Inc.
Jerry R. Youkey active positions
| Companies | Position | Start |
|---|---|---|
| University of South Carolina | Corporate Officer/Principal | 2009-09-17 |
| Medical University of South Carolina | Corporate Officer/Principal | 2009-09-17 |
Former positions of Jerry R. Youkey
| Companies | Position | End |
|---|---|---|
| ONCOLIX, INC. | Director/Board Member | 2019-03-05 |
Greenville Hospital System (South Carolina)
 Greenville Hospital System (South Carolina) Hospital/Nursing ManagementHealth Services Greenville Hospital System (South Carolina) engages in the provision of general medical services. Its services include cancer institute, specialty medicine, neuroscience institute, health and vascular institute, orthopedics, surgery, children's hospital, primary care, and women's health. The company was founded in 1912 and is headquartered in Greenville, SC. | Corporate Officer/Principal | - |
Geisinger Medical Center
 Geisinger Medical Center Hospital/Nursing ManagementHealth Services Geisinger Medical Center provides healthcare, education and research services. The firm offers allergy, heart, cancer, hematology, neonatology, rehabilitation, community health and women care services. The company is headquartered in Danville, PA. | Corporate Officer/Principal | - |
Oncolix, Inc. /Old/
 Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Chairman | - |
Training of Jerry R. Youkey
| Stanford University | Undergraduate Degree |
| The Medical College of Wisconsin, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Oncolix, Inc. /Old/
Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Health Technology |
Greenville Hospital System (South Carolina)
Greenville Hospital System (South Carolina) Hospital/Nursing ManagementHealth Services Greenville Hospital System (South Carolina) engages in the provision of general medical services. Its services include cancer institute, specialty medicine, neuroscience institute, health and vascular institute, orthopedics, surgery, children's hospital, primary care, and women's health. The company was founded in 1912 and is headquartered in Greenville, SC. | Health Services |
Geisinger Medical Center
Geisinger Medical Center Hospital/Nursing ManagementHealth Services Geisinger Medical Center provides healthcare, education and research services. The firm offers allergy, heart, cancer, hematology, neonatology, rehabilitation, community health and women care services. The company is headquartered in Danville, PA. | Health Services |
Oncolix, Inc.
 Oncolix, Inc. Pharmaceuticals: MajorHealth Technology Oncolix, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of medical therapies for the treatment of various cancers including ovarian, breast, uterine, and prostate. Its brand Prolanta is a drug designed to block the effect of human prolactin in cancers, either as a stand-alone therapy or in combination with other drugs, by blocking the effect of human prolactin. The company was founded on June 2013 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Jerry R. Youkey
